3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning. It focuses on methods for novel drug target discovery, drug candidate generation, and safety assessment. The company also offers genetic and biomolecular testing services that analyze biologic samples from patients suspected of having rare genetic disorders, along with related services. Founded in 2016, it is based in Seoul, South Korea.